Clinical Trials
5 trialsNCT07544589 2026-05-29
A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers
Dispatch Biotherapeutics
Phase 1 Recruiting
NCT05271318 2026-05-05
PROTA
TILT Biotherapeutics Ltd.
Phase 1/2 Active not recruiting
NCT02143804 2026-04-02
exBOND
CG Oncology, Inc.
Phase 2 Withdrawn
NCT06763965 2026-03-23
Evaluating the Safety and Efficacy of BioTTT001 in Patients With Recurrent/Progressive High-grade Glioma.
Beijing Bio-Targeting Therapeutics Technology Co., Ltd
Phase 1/2 Enrolling by invitation
NCT04695327 2026-03-06
TUNIMO
TILT Biotherapeutics Ltd.
Phase 1 Completed